Compare Msci Inc (MSCI) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Msci Inc vs Tempus AI — how do they compare? Msci Inc trades at $562 (market cap $40.94B), while Tempus AI trades at $55.5 (market cap $9.93B). The key difference: Msci Inc is far larger — about 4.1× Tempus AI's market cap, and Msci Inc pays a 1.46% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| MSCI | TEM | |
|---|---|---|
Market Cap | $40.94B | $9.93B |
Sector | Financials | Broad Market / Factor |
52-Week High | $643.83 | $103.25 |
52-Week Low | $511.84 | $41.55 |
Enterprise Value | $47.10B | $10.56B |
Dividend Yield | 1.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSCI trades at $563.17, down 0.72% with bearish technical signals but strong fundamentals including 40.73% net margins and consistent earnings beats. The company shows robust revenue growth from $2.2B in 2022 to $3.13B in 2025, with positive cash flow trends. Recent acquisitions like First Street and partnerships with UBS enhance its private markets platform, supporting long-term growth in climate risk analytics and alternative investments.
Wall Street maintains strong bullish sentiment with 73% buy ratings and a $728.14 consensus target, implying 29% upside. Key risks include high debt levels at $4.51B and sensitivity to market cycles, but recurring revenue models and strategic expansions position MSCI for sustained outperformance despite near-term technical weakness.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
